• DFO Latent Fingerprint Detection Workflow

  2026-09-18

  DFO combines amino-acid reactivity with fluorescence to improve latent print visualization on paper and other porous evidence. This practical guide covers solvent selection, controlled development, imaging controls, troubleshooting, and how to interpret a separate ferroptosis study without conflating forensic and cancer-assay applications.

• BmTyr Click Labeling in Primary T Cells

  2026-09-17

  The reference study introduces a copper-dependent BmTyr proximity-labeling platform that replaces biotin with an alkyne-phenol probe and versatile azide-bearing readout tags. In primary T cells, the approach supports imaging, affinity enrichment, mass spectrometry, and sensitive chemiluminescent validation while identifying a previously underappreciated chromatin-associated localization of NKAP.

• WST-8 Glucose Uptake Assay Kit and Autophagy

  2026-09-17

  Discover how the WST-8 Glucose Uptake Assay Kit can connect cellular glucose handling with autophagy and insulin-resistance mechanisms. This article translates findings from a recent Galectin-1–FIP200 study into a rigorous, non-radioactive glucose uptake assay strategy.

• CX-5461 RNA Polymerase I Inhibitor Workflow

  2026-09-16

  CX-5461 connects ribosomal RNA suppression with DNA damage, mitotic catastrophe, autophagy, and cellular senescence in solid-tumor models. This practical workflow shows how to manage formulation, time-resolved mechanism assays, cisplatin combinations, and translational interpretation.

• PEtOx-Lipid LNPs as PEG Alternatives for mRNA

  2026-09-16

  Holick and colleagues evaluate poly(2-ethyl-2-oxazoline)-lipids as substitutes for PEG-lipids in mRNA lipid nanoparticles, focusing on how polymer chain length affects particle properties, immune response, and transfection. Their combination of physicochemical characterization, biological assays, and super-resolution microscopy identifies a PEtOx formulation with a stronger overall performance profile than the commercial PEG-lipid comparator used in Comirnaty.

• YAP–TEAD Super-Enhancers in Ectoderm Commitment

  2026-09-15

  A 2026 Nucleic Acids Research study maps how super-enhancer networks and YAP–TEAD activity coordinate early surface ectoderm commitment from pluripotent stem cells. Its combination of three-dimensional genome analysis, CRISPR-dCas9 perturbation, and transcription-factor network modeling connects enhancer architecture with functional lineage control.

• YAP–TEAD Super-Enhancers in Ectoderm Commitment

  2026-09-15

  Wang et al. map how YAP–TEAD activity organizes super-enhancer networks during early surface ectoderm commitment from pluripotent stem cells. By combining three-dimensional genomic profiling, CRISPR-dCas9 perturbation, and transcription-factor experiments, the study connects enhancer architecture with lineage progression and epithelial regeneration research.

• Angiotensin 1/2 (2-7): Assay Design Guide

  2026-09-14

  Explore how Angiotensin 1/2 (2-7) can sharpen blood pressure regulation research through sequence-aware assay design. This guide connects product specifications with recent evidence on angiotensin peptide effects in spike–receptor binding assays while clearly defining translational limits.

• H3K18 Lactylation Drives Colorectal Cancer Progression

  2026-09-14

  The reference study identifies an H3K18 lactylation–METTL5–CCT2 pathway that links lactate metabolism, chromatin regulation, m6A RNA modification, and pyroptosis suppression in colorectal cancer. Its multi-omic and functional design provides a framework for validating pathway-associated transcripts, while the proposed AZD6482–oxaliplatin combination remains a preclinical finding requiring further study.

• β-Amanitin: From Transcription to Toxin Detection

  2026-09-13

  β-Amanitin is more than a potent RNA polymerase II inhibitor: it is a mechanistic tool for linking transcriptional perturbation with modern amatoxin detection. This article explains how its molecular action, assay design, and analytical limitations inform reproducible research workflows.

• ABT-263 (Navitoclax) in Apoptosis Workflows

  2026-09-12

  ABT-263 (Navitoclax) gives cancer biology researchers a mechanistically focused way to test Bcl-2 family dependence, therapy-induced senescence, and mitochondrial apoptotic priming. This workflow-oriented guide connects compound handling with apoptosis assay design, resistance analysis, and translational cancer models.

• Breast Cancer Dependence on MCL-1: Study Insights

  2026-09-11

  A 2021 Cell Death & Differentiation study shows that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic control of BAX and BAK. Genetic deletion and selective pharmacological inhibition both restricted tumor growth, while loss of BAX/BAK prevented these effects, clarifying the mechanistic basis for MCL-1-directed apoptosis research.

• Dimetridazole: Applied Research Workflows

  2026-09-11

  Dimetridazole supports more than antimicrobial screening: it can connect bacterial culture assays, quorum-sensing and biofilm studies, combination testing, and highly sensitive electrochemical measurement. This guide translates its chemistry and the validated molecularly imprinted sensor approach into practical, controlled workflows while emphasizing assay controls, matrix effects, and regulatory limitations.

• Sulfo-NHS-SS-Biotin for Surface Assay Design

  2026-09-10

  Sulfo-NHS-SS-Biotin enables selective, cleavable labeling of externally exposed proteins. This guide explains how its chemistry can distinguish surface abundance from total protein in trafficking and affinity workflows, using NMDAR biology to sharpen assay interpretation.

• Maternal Surgery, Calpain, and Offspring Cognition

  2026-09-10

  A 2025 Neuropharmacology study identifies excessive calpain activity and impaired BDNF/TrkB signaling as mechanistic links between maternal non-obstetric surgery during pregnancy and cognitive deficits in offspring. Its combination of behavioral, structural, molecular, and pharmacological evidence positions calpain inhibition as a testable strategy in developmental neuroprotection research, while also defining important limits for translation.

817 records 7/55 page Previous Next First page 上5页 678910 下5页 Last page